Intradermal Injection Market is CAGR of 10.8% from 2022 to 2032

The global Intradermal Injection Market is expected to exceed an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% projected from 2022 to 2032. Technological advancements in recent years have resulted in the development of surgical approaches with the goal of minimising waste and achieving better results. Reusable intradermal devices result in low waste generation, which has a net positive effect on an economy’s productivity.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15855

Furthermore, the findings of several meta-analyses show that intradermal drug delivery reduces the severity of adverse events. The aforementioned factors point to a favourable future environment for this segment’s rapid growth. The rising prevalence of tuberculosis is expected to boost the intradermal injection market’s growth rate. According to WHO data, tuberculosis is the 13th leading cause of death, with approximately 10 million cases of TB recorded each year, resulting in a dramatic increase in the diagnostic rate of TB over the last decade.

This is one of the major factors contributing to the growth of the intradermal injection market for tuberculin syringes. The American Cancer Society’s 2022 report predicts that over 1.9 million new cancers will be diagnosed in the United States in 2022. According to the same source, the risk of developing cancer increases dramatically with age, with 80% of cancer patients in the United States being 55 or older, and 57% being 65 or older. According to these figures, the growing geriatric population is expected to have a significant positive impact on market growth.

Key Takeaways from Market Study

• The global Intradermal Injection market is expected to be worth $10,814.47 million.
• From 2022 to 2032, the market is expected to grow at a compound annual growth rate (CAGR) of 10.8%.
• The Europe Intradermal Injection market is expected to grow significantly, with the United Kingdom acquiring a sizable share.
• In terms of revenue and market share, North America was the most profitable regional segment.
• Normal sized needles dominate the market in terms of method.
• The tuberculin skin test segment is estimated to have the largest share by application.

“The growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes, intradermal jet injectors, microinjections, and ballistic intradermal injections treatment and diagnostic purposes,” says an analyst at Future Market Insights.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15855

Key Market Players

Major players are channeling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market. Key players in the Intradermal Injection market are Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.

• Stevanato Group S.p.A. signed an exclusive agreement for its Aidaptus auto-injector with leading medical device developer and manufacturer Owen Mumford Ltd. in May 2022. Aidaptus is a two-step, single-use auto-injector with a flexible design that can hold both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
• Takeda Pharmaceutical Company Limited received European Commission approval for the subcutaneous (SC) formulation of Entyvio (vedolizumab), a gut-selective biologic intended for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease, in May 2020. (CD). Entyvio SC is available as a pre-filled syringe as well as a pre-filled pen.
• Terumo Corporation is a forerunner in hypodermic needle development. The company provides a comprehensive platform of precision-engineered needle and needle stick prevention technologies, which are ready for the most difficult applications and high-throughput processing environments. To ensure the therapeutic success of the drug product, the company assists in the design and delivery of safer, less painful injections. The Nanopass® 34G Needle for Pen Injectors, the Neolus Needles, the SurGuard® Safety Hypodermic Needles, the SurGuard® 3 Safety Hypodermic Needles, and the Terumo 3-Part Syringe are among its products.
• Crossject announced an expansion of its partnership with long-term collaborator Cenexi in May 2021 to ramp up industrial scale manufacturing of the ZENEO® needle-free auto-injection. Cenexi strengthened its position on innovation and sterile manufacturing expertise with this announcement, owing to its human-scale agility and recognised skills in pharmaceutical development.

Buy Now@ https://www.futuremarketinsights.com/checkout/15855

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Intradermal Injection market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Method (Normal Sized Needles, Short Needle (Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices], and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors]), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) & Region.

About the Technology at Future Market Insights 

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs